Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
2 pathways triggered by insulin
|
MAPK
PI3K |
|
MAPK causes ___ (2)
|
growth
differentiation |
|
PI3K causes ___
|
GLUT4 translocation
|
|
95% of DM1 patients have ___ or ___
|
HLA-DR3
HLA-DR4 |
|
in early DM1, beta cells abnormally express ___
|
HLA class II
|
|
___ released by T cells and ___ released by macrophages damages beta cells
|
IFNgamma
IL1 TNFa |
|
4 Abs present in DM1
|
anti islet
anti insulin anti glutamic acid decarboxylase (GAD) anti bovine serum albumin (BSA) |
|
DM1 and DM2 are both ___ diabetes
|
primary (idiopathic)
|
|
2 kinds of secondary diabetes
___ is more common |
pancreatic dysfunction
endocrine (?) endocrine |
|
secondary diabetes is common/rare
|
rare
|
|
6 viruses associated with DM1
|
rubella
coxsackie mumps measles CMV EBV |
|
cow milk can cause DM1 because an autoimmune ___ occurs between ___ and ___
|
cross reaction
BSA beta cell p69 |
|
in DM2, although concordance between identical twins is ___%, there is no ___
|
50-90
HLA association |
|
T/F: in DM2 insulin levels eventually reach 0
|
false
|
|
insulin resistance in DM2 is due to reduced function and number of ___ (2)
|
insulin receptors
GLUT4 |
|
reduced insulin secretion in DM2 is due to reduced function and number of ___
|
beta cell GLUT2
|
|
late in DM2 ___ is present in beta cells
|
amyloid
|
|
complications of DM depend on ___ and ___ of hyperglycemia
|
duration
severity |
|
3 mechanisms of DM complications
|
non-enzymatic glycation
aldose reductase PKC activation |
|
T/F: non-enzymatic glycation is irreversible
|
true
|
|
non-enzymatic glycation forms ___s
|
advanced glycation end-products (AGE)
|
|
the main problem with AGEs is ___
|
they resist proteolysis
|
|
AGEs bind ___ in the arterial ___. this causes ___
|
LDLs
intima increased atherosclerosis |
|
in small vessels AGEs cause ___, which causes ___
|
increased BM collagen 4
microangiopathy |
|
aldose reductase converts ___ to ___. it is present in ___
|
glucose
sorbitol Schwann cells retinal capillary pericytes lens |
|
in DM, activation of aldose reductase in Schwann cells causes ___, in retinal capillaries causes ___, and in lens causes ___.
|
neuropathy
retinal microaneurysms cataracts |
|
in DM activation of PKC causes release of ___, which causes ___ (2)
|
VEGF
increased BM deposition increased tPAI |
|
complications of DM take ___ years to develop and depend on ___
|
10-15
severity of hyperglycemia |
|
6 DM complications
|
capillary BM thickening
accelerated atherosclerosis ocular (retinopathy) neuropathy renal infections |
|
capillary BM thickening is aka ___ and causes ___
|
microangiopathy
ischemia proteinuria |
|
protein leakage in DM is due to increased ___ and decreased ___
|
BM collagen 4
polyanionic proteoglycans |
|
DM causes ___fold increase in MI risk. the increase is higher/lower in women of reproductive age
|
2.5
hgher |
|
DM causes ___fold increase in risk of blindness.
|
20
|
|
2 kinds of DM retinopathy
|
nonproliferative
proliferative |
|
earliest change to appear in nonproliferative retinopathy is characterized by ___, which is identified via ___. later changes are
|
capillary leakage
fluorescein angiography capillary obstruction microaneurysm |
|
___ are pathognomonic for DM and are present in all patients with ___
|
retinal microaneurysms
nodular GS |
|
in proliferative retinopathy ____s grow ___ly into ___. this can cause ___ and ___
|
blood vessels
anterior vitreous humor retinal detachment blindness |
|
tx for both kinds of retinopathy
|
photocoagulation of vessels
|
|
2 kinds of DM neuropathy
|
symmetric peripheral
autonomic |
|
symmetric peripheral neuropathy causes ___ and ___ defects
|
sensory
motor |
|
tendency for infection is due to ___ (2)
|
leukocyte dysfunction
vascular disease |
|
pancreatic change in late DM2
|
amyloidosis
|
|
amyloid in DM2 is ___, a protein normally secreted by ___
|
amylin
beta cells |